- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 45 Years - 99 Years
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Dominick J Angiolillo, MD, PhD
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 416 publications
- Percutaneous Coronary Intervention , 211 publications
- Clopidogrel , 189 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 65 Years
- Sexes
- All
My publications
Filter publications
844 publications
2025
Persistent Tic Disorders Are Associated With 17q12 Duplications.
Research square
鈥�2025
CYP2C19 Phenotype, P2Y 12 Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy
Journal of the American Heart Association
2025
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
European Heart Journal
2025
Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction-DAPA-STEMI Trial.
Journal of cardiovascular development and disease
鈥�2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
鈥�